Equities

Lifestance Health Group Inc

LFST:NSQ

Lifestance Health Group Inc

Actions
  • Price (USD)7.40
  • Today's Change0.01 / 0.14%
  • Shares traded1.67m
  • 1 Year change+31.91%
  • Beta1.2655
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Lifestance Health Group Inc grew revenues 22.82% from 859.54m to 1.06bn while net income improved from a loss of 215.56m to a smaller loss of 186.26m.
Gross margin--
Net profit margin-7.90%
Operating margin-5.45%
Return on assets-4.45%
Return on equity-6.59%
Return on investment-4.98%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Lifestance Health Group Inc fell by 29.80m. Cash Flow from Financing totalled 47.43m or 4.49% of revenues. In addition the company used 16.88m for operations while cash used for investing totalled 60.34m.
Cash flow per share-0.0445
Price/Cash flow per share--
Book value per share3.76
Tangible book value per share-0.1349
More ▼

Balance sheet in USDView more

Lifestance Health Group Inc has a Debt to Total Capital ratio of 16.40%, a lower figure than the previous year's 17.07%.
Current ratio1.32
Quick ratio--
Total debt/total equity0.1962
Total debt/total capital0.164
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.